
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
05/06/2025 | Q1 | -- | $2.4B | $0.54 | -- | -- |
02/04/2025 | Q4 | -- | $2.3B | -$0.77 | -- | -- |
10/30/2024 | Q3 | -- | $2.5B | $0.63 | -- | -- |
07/30/2024 | Q2 | -- | $2.4B | $0.54 | -- | -- |
05/02/2024 | Q1 | -- | $2.3B | $0.53 | -- | -- |
02/22/2024 | Q4 | -- | $2.2B | $0.20 | -- | -- |
09/30/2023 | Q3 | -- | $2.4B | $0.73 | -- | -- |
06/30/2023 | Q2 | -- | $2.4B | $0.48 | -- | -- |
03/31/2023 | Q1 | -- | $2.6B | $0.52 | -- | -- |
12/31/2022 | Q4 | -- | $3B | $0.63 | -- | -- |
09/30/2022 | Q3 | -- | $2.7B | $0.83 | -- | -- |
06/30/2022 | Q2 | -- | $2.4B | $1.03 | -- | -- |
03/31/2022 | Q1 | -- | $2B | $0.36 | -- | -- |
12/31/2021 | Q4 | -- | $1.9B | $0.25 | -- | -- |
11/12/2021 | Q3 | -- | $1.6B | $0.40 | -- | -- |
08/11/2021 | Q2 | -- | $1.6B | $0.34 | -- | -- |
05/14/2021 | Q1 | -- | $1.4B | $0.18 | -- | -- |
12/31/2020 | Q4 | -- | $1.4B | $0.17 | -- | -- |
11/12/2020 | Q3 | -- | $1.5B | $0.18 | -- | -- |
08/11/2020 | Q2 | -- | $1.4B | $0.15 | -- | -- |
05/14/2020 | Q1 | -- | $1.5B | $0.14 | -- | -- |
12/31/2019 | Q4 | -- | $1.8B | $0.28 | -- | -- |
09/30/2019 | Q3 | -- | $1.5B | $0.24 | -- | -- |
06/30/2019 | Q2 | -- | $1.5B | $0.28 | -- | -- |
03/31/2019 | Q1 | -- | $1.4B | $0.18 | -- | -- |
12/31/2018 | Q4 | -- | $1.5B | $0.03 | -- | -- |
09/30/2018 | Q3 | -- | $1.5B | $0.37 | -- | -- |
06/30/2018 | Q2 | -- | $1.7B | $0.31 | -- | -- |
03/31/2018 | Q1 | -- | $1.6B | $0.36 | -- | -- |
12/31/2017 | Q4 | -- | $1.7B | $0.18 | -- | -- |
09/30/2017 | Q3 | -- | $1.5B | $0.29 | -- | -- |
06/30/2017 | Q2 | -- | $1.4B | $0.31 | -- | -- |
03/31/2017 | Q1 | -- | $1.3B | $0.18 | -- | -- |
12/31/2016 | Q4 | -- | $1.3B | $0.06 | -- | -- |
09/30/2016 | Q3 | -- | $1.2B | $0.18 | -- | -- |
06/30/2016 | Q2 | -- | $1.4B | $0.09 | -- | -- |
03/31/2016 | Q1 | -- | $1.2B | $0.11 | -- | -- |
12/31/2015 | Q4 | -- | $1.4B | -$0.08 | -- | -- |
09/30/2015 | Q3 | -- | $1.3B | $0.18 | -- | -- |
Raiffeisen Bank International AG reported $2.4B worth of top line sales in its most recent quarter.
Raiffeisen Bank International AG announced earnings per share of $0.54 which represents a beat of analyst forecast a -- per share.
Raiffeisen Bank International AG reported -- that represents -- per share over the last quarter.
Raiffeisen Bank International AG's earnings are forecast to grow from $0.86 per share to -- per share next year representing an increase of --.
Raiffeisen Bank International AG's next earnings date is July 30, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.